| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| composé radio-isotopique pour diagnostic et/ou traitement |
Is a |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Radiopaque agent |
Is a |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Allergy to radiopharmaceutical |
Causative agent (attribute) |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Yttrium-90 microspheres |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Tositumomab 14mg/mL/Iodine 131 5.6mCi/mL/Tositumomab 1.1mg/mL injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| produits pharmaco-radioactifs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing phosphorus-32 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium phosphate[32P]74MBq/mL injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium phosphate[32P] 185MBq/mL injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing strontium-89 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Strontium[89Sr] chloride 37MBq/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing yttrium-90 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Yttrium[90Y] silicate injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Iodine-131(therapy) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium iodide[131I] 925MBq/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium iodide[131I]740MBq/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium iodide[131I]37-5550MBq therapy capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium iodide[131I] 74MBq/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium iodide[131I] 370MBq/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium iodide[131I] 3700MBq/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing erbium-169 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Erbium[169Er]citrate 37-185MBq/mL colloidal injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing rhenium-186 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Rhenium[186Re]37-370MBq/mL colloidal injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Rhenium[186Re]hydroxyethylidene diphosphonate 1295MBq injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing carbon-14 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Diethylamine-[14C] aminopyrine solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Glycerol-[14C] trioleate solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Urea[14C] solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing fluorine-18 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing calcium-45 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Calcium[45Ca]chloride 3.7-185MBq/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing calcium-47 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Calcium[47Ca]chloride 0.74-3.7MBq/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing chromium-51 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Chromium[51Cr] edetate 3.7MBq/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium chromate[51Cr] 37MBq/mL sterile solution BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Chromic[51Cr] chloride 37MBq/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Chromic[51Cr] chloride 3.7MBq/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium chromate[51Cr] 74MBq/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing cobalt-57 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Cyanocobalamin[57Co] 370kBq/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing precisely cobalt-57 18.5 kilobecquerel/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing cobalt-57 and cobalt-58 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Cyanocobalamin[57Co] capsule+cyanocobalamin[58Co] capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing cobalt-58 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Cyanocobalamin[58Co] 370kBq/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing iron-59 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Ferric citrate[59Fe]7.4MBq/mL injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Ferric citrate[59Fe] 3.7MBq/mL injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing gallium-67 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing selenium-75 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| 6-Methyl[75Se]selenomethyl-19-norcholest-5(10)-en-3B-ol injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing technetium-99m (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Lymphatic system imaging agents and kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Hepatobiliary imaging agents and kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Heart and cardiovascular imaging agents and kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Kidney imaging agents and kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Brain imaging agents and kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Lung perfusion imaging agents and kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Lung ventilation imaging agents and kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Bone imaging agents and kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Bone marrow imaging agents and kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Blood pooling imaging agents and kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Technetium stannous agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Liver and spleen imaging agents and kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Infection/inflammation imaging agents and kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Endocrine/exocrine imaging agents and kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing indium-111 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Indium[111In]oxine 37MBq/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Indium chloride[111In] 370MBq/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Calcium diethylenetriaminepentaacetate[111In] 37MBq/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Indium-111 labeling kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Colorectal imaging agents and kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Endocrine imaging agents and kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Pentetreotide+indium chloride[111In] 10micrograms/111MBq/mL injection kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Myocardial imaging agents and kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing indium-113m (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Indium-113m labeling kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing indium diethylenetriamine penta-acetic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing indium colloid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing indium phytate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing iodine-123 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium iodohippurate[123I]37MBq/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium iodide (123-I) 3.7 MBq oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium iodide[123I] 37MBq/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Iodine-123 labeling kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Brain imaging agent and kits- [I123] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Tumor imaging agents and kits |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Metaiodobenzylguanidine labeling kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Product containing iodine-125 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Iodinated[125I] human albumin 1.85MBq/mL injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Iodinated[125I] human albumin >148kBq/mL injection+syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium iodide[131I] 333kBq-3.7MBq diagnostic capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium iodide[131I] 74MBq/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium iodide[131I] 3.7MBq/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium iodide[131I] 18.5MBq/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium iodide[131I] 37MBq/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium iodohippurate[131I]18.5MBq/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium iodohippurate[131I]20MBq/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
| Sodium iodohippurate[131I]7.4MBq/1mL injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent radiopharmaceutique |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]